To Compete With China, US FDA Must Deregulate Early Gene Therapy Studies, CAR-T Inventor Says

FDA regulation was painted as an obstacle to US dominance in the cell and gene therapy space even as panelists at an agency event praised the Office of Therapeutic Products' track record under Nicole Verdun.